Wealthfront Advisers
HIMS icon

Wealthfront Advisers’s Hims & Hers Health HIMS Stock Holding History

Wealthfront Advisers’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$934K Sell
26,931
-657
-2% -$17.6K ﹤0.01% 738
2026
Q1 		$573K Buy
27,588
+11,201
+68% +$265K ﹤0.01% 810
2025
Q4 		$532K Sell
16,387
-1,747
-10% -$74.8K ﹤0.01% 807
2025
Q3 		$1.03M Buy
18,134
+12,823
+241% +$657K ﹤0.01% 691
2025
Q2 		$265K Buy
+5,311
New +$240K ﹤0.01% 892

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wealthfront Advisers's HIMS Position: Q2 2026 in Review

Wealthfront Advisers reduced its Hims & Hers Health (HIMS) stake by 2.4% in Q2 2026, selling an estimated $17.6K and leaving 26,931 shares worth $934K. The position accounts for ﹤0.01% of the portfolio, ranked #738.

Wealthfront Advisers first reported a position in HIMS in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.03M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Wealthfront Advisers held 26,931 shares of Hims & Hers Health worth $934K as of Q2 2026.
  • Wealthfront Advisers sold 657 Hims & Hers Health shares in Q2 2026, an estimated $17.6K.
  • Hims & Hers Health made up ﹤0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #738 holding.
  • Wealthfront Advisers first reported a position in Hims & Hers Health in Q2 2025 and has held it in 5 quarters since.
  • Wealthfront Advisers's Hims & Hers Health position peaked at $1.03M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.